The latest closing stock price for Kiniksa Pharmaceuticals as of March 27, 2025 is 23.36.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $200 today, roughly 0 times their original investment - a 2.64% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 20.5% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 29.1% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.65.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $200 today, roughly 0 times their original investment - a 2.64% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 20.5% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 29.1% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.65.